- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Cluster of Differentiation 34 (CD34) is a transmembrane sialomucin glycoprotein encoded by the CD34 gene and is widely expressed on vascular endothelial cells and hematopoietic progenitor cells. It plays a role in cell adhesion and vascular organization and is a defining marker of endothelial cells. CD34 Antibody / Tumor Angiogenesis Marker Antibody is widely used to investigate tumor-associated vasculature, where it enables visualization of abnormal vascular networks that support tumor growth and progression.
CD34 antibody, also known as endothelial marker antibody or angiogenesis marker antibody, highlights endothelial cells lining tumor-associated blood vessels, producing a distinct membranous staining pattern that outlines irregular vascular structures within tumor tissue. Unlike normal tissues, tumor vasculature often appears disorganized, tortuous, and unevenly distributed, and CD34 staining allows these features to be clearly visualized.
This CD34 Antibody / Tumor Angiogenesis Marker Antibody is uniquely positioned for cancer-focused studies, where characterization of vascular abnormalities is critical for understanding tumor biology. CD34-positive endothelial cells form dense and irregular microvascular networks within tumors, and these structures can be directly visualized to assess vascular heterogeneity and angiogenic remodeling.
CD34 staining is frequently used to identify regions of increased vascularization within tumors, including areas of high microvessel density and angiogenic activity. These regions often correspond to areas of rapid tumor growth and metabolic demand, and their identification supports analysis of tumor structure and microenvironment organization.
In addition to primary tumors, CD34 is also used to examine vascularization in metastatic lesions and tumor-associated stromal compartments, where vascular patterns may differ depending on tumor type and location. The ability to detect endothelial cells across these contexts supports detailed investigation of tumor vascular biology.
Overall, CD34 Antibody / Tumor Angiogenesis Marker Antibody rHPCA1/8573 provides robust detection of tumor-associated endothelial cells, enabling detailed visualization of abnormal vascular networks, angiogenic remodeling, and microvascular organization in cancer research.
This antibody is part of our CD34 antibody collection, supporting research into stem cell biology, endothelial markers, and tumor angiogenesis.
Optimal dilution of the CD34 Antibody / Tumor Angiogenesis Marker Antibody should be determined by the researcher.
A recombinant partial protein sequence (within amino acids 100-300) from the human protein was used as the immunogen for the CD34 antibody.
Aliquot the CD34 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
CD34 tumor angiogenesis antibody, CD34 cancer vascular marker antibody, CD34 tumor endothelial marker antibody, CD34 tumor vessel marker antibody, CD34 neovascularization antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.